Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Pulkki-Råback, L, Elovainio, M, Hakulinen, C, Lipsanen, J, Kubzansky, LD, Hintsanen, M, Savelieva, K, Serlachius, A, Magnussen, CG, Sabin, MA, et al.
Positive Psychosocial Factors in Childhood Predicting Lower Risk for Adult Type 2 Diabetes: The Cardiovascular Risk in Young Finns Study, 1980-2012..
Am J Prev Med
52(6)
:
e157 -e164
2017
view publication
Chen, KY, Zannino, D, Curtis, N, Cheung, M, Burgner, D.
Increased aortic intima-media thickness following Kawasaki disease..
Atherosclerosis
260:
75 -80
2017
view publication
Burgner, DP, Doherty, D, Humphreys, J, Currie, A, Simmer, K, Charles, A, Strunk, T.
Maternal Chorioamnionitis and Postneonatal Respiratory Tract Infection in Ex-Preterm Infants..
J Pediatr
184:
62 -67.e2
2017
view publication
Spelman, D, Jenney, AW, Burgner, DP.
Australasian Society for Infectious Diseases: low value interventions..
Med J Aust
206(7)
:
282 -283
2017
view publication
Phuong, LK, Singh-Grewal, D, Burgner, DP.
Caution in Generalizing the Use of Adjunctive Primary Corticosteroids in Kawasaki Disease to Unselected Non-Japanese Populations..
JAMA Pediatr
171(4)
:
397 -398
2017
view publication